# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001913
Filing Date
2024-11-13
Accepted
2024-11-13 06:50:25
Documents
60
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lptx-20240930x10q.htm iXBRL | 10-Q | 1591179
2 | EX-31.1 | lptx-20240930xex31d1.htm | EX-31.1 | 14336
3 | EX-32.1 | lptx-20240930xex32d1.htm | EX-32.1 | 10108
| Complete submission text file | 0001410578-24-001913.txt |  | 6287066

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | EX-101.SCH | lptx-20240930.xsd | EX-101.SCH | 45732
5 | EX-101.CAL | lptx-20240930_cal.xml | EX-101.CAL | 38302
6 | EX-101.DEF | lptx-20240930_def.xml | EX-101.DEF | 162917
7 | EX-101.LAB | lptx-20240930_lab.xml | EX-101.LAB | 419866
8 | EX-101.PRE | lptx-20240930_pre.xml | EX-101.PRE | 289185
63 | EXTRACTED XBRL INSTANCE DOCUMENT | lptx-20240930x10q_htm.xml | XML | 974123

Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 241451096
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)